The BioNTech vaccine will be available in Germany from mid-October for the 5-11 age group, co-founder Ezlem Turezzi told Der Spiegel.
The company warns that 2 more months remain to avoid a dire situation with coronavirus in winter. Ms Turetsi notes:
“In the coming weeks, we will present the results of our study for children aged 5-11 to authorities around the world and will apply for approval of a vaccine for this age group here in Europe. We are already preparing the production. The vaccine will be the same, but at a lower dose. Everything looks fine, everything is going according to plan. “
She also says that by the end of the year, the results of studies on the use of the vaccine for very small children – from 6 months will be ready. Turetsi urged citizens of all ages to be vaccinated immediately ahead of winter: “We, as a society, have 60 more days to prevent a hard winter,” we must do our best to mobilize as many people as possible. “Every additional vaccination helps. We must not give up, ”she concluded.
Health Minister Jens Spann, as reported by the APE-MPE correspondent in Berlin, said on the air of the RND TV channel:
“This is good news. The approval of the vaccine will contribute to better protection for children. The vaccine produced in Germany is a good thing for the world.”
Several countries have already started vaccinating children under 12 years of age. Next week they will be joined by Chile, where they will start vaccinating children from 6 years old.